Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Metoclopramide Orally Disintegrating Tabs Generic Name & Formulations
Legal Class
Rx
General Description
Metoclopramide (as HCl) 5mg; mint flavor.
Pharmacological Class
Prokinetic.
How Supplied
Contact supplier
Manufacturer
Metoclopramide Orally Disintegrating Tabs Indications
Indications
Short-term (4–12 weeks) therapy for symptomatic refractory GERD.
Metoclopramide Orally Disintegrating Tabs Dosage and Administration
Adult
Allow tablet to dissolve on tongue. 10–15mg 4 times daily 30mins before meals and at bedtime. Intermittent symptoms: up to 20mg prior to provoking situation; max 12 weeks per therapeutic course. Renal impairment: reduce dose.
Children
Not established.
Metoclopramide Orally Disintegrating Tabs Contraindications
Contraindications
When stimulation of GI motility may be dangerous (eg, obstruction, perforation, or hemorrhage). Pheochromocytoma. Epilepsy. Concomitant drugs which may cause extrapyramidal reactions (eg, antidepressants, antipsychotics, neuroleptics).
Metoclopramide Orally Disintegrating Tabs Boxed Warnings
Not Applicable
Metoclopramide Orally Disintegrating Tabs Warnings/Precautions
Warnings/Precautions
Discontinue if signs/symptoms of tardive dyskinesia develop; risk increases with duration of treatment and total cumulative dose. Parkinsonism. History of depression. Hypertension. CHF. Arrhythmia. Elderly. Pregnancy (Cat.B). Nursing mothers.
Metoclopramide Orally Disintegrating Tabs Pharmacokinetics
See Literature
Metoclopramide Orally Disintegrating Tabs Interactions
Interactions
Hypertensive crisis with MAOIs. Additive sedation with alcohol, other CNS depressants. Antagonized by anticholinergics and narcotics. Monitor insulin use; may diminish gastric and accelerate intestinal absorption of drugs or food.
Metoclopramide Orally Disintegrating Tabs Adverse Reactions
Adverse Reactions
Headache, nausea, vomiting, fatigue, somnolence, dizziness, extrapyramidal effects, parkinsonism, tardive dyskinesia, neuroleptic malignant syndrome, hypertension.
Metoclopramide Orally Disintegrating Tabs Clinical Trials
See Literature
Metoclopramide Orally Disintegrating Tabs Note
Notes
Formerly known under the brand name Metozolv ODT.
Metoclopramide Orally Disintegrating Tabs Patient Counseling
See Literature
Metoclopramide Orally Disintegrating Tabs Generic Name & Formulations
Legal Class
Rx
General Description
Metoclopramide (as HCl) 5mg; mint flavor.
Pharmacological Class
Antidopaminergic.
How Supplied
Contact supplier
Manufacturer
Metoclopramide Orally Disintegrating Tabs Indications
Indications
To relieve symptoms associated with acute and recurrent diabetic gastroparesis.
Metoclopramide Orally Disintegrating Tabs Dosage and Administration
Adult
Allow tablet to dissolve on tongue. 10mg 4 times daily 30mins before meals and at bedtime for 2–8 weeks. Renal impairment: reduce dose.
Children
Not established.
Metoclopramide Orally Disintegrating Tabs Contraindications
Contraindications
When stimulation of GI motility may be dangerous (eg, obstruction, perforation, or hemorrhage). Pheochromocytoma. Epilepsy. Concomitant drugs which may cause extrapyramidal reactions (eg, antidepressants, antipsychotics, neuroleptics).
Metoclopramide Orally Disintegrating Tabs Boxed Warnings
Not Applicable
Metoclopramide Orally Disintegrating Tabs Warnings/Precautions
Warnings/Precautions
Discontinue if signs/symptoms of tardive dyskinesia develop; risk increases with duration of treatment and total cumulative dose. Parkinsonism. History of depression. Hypertension. CHF. Arrhythmia. Elderly. Pregnancy (Cat.B). Nursing mothers.
Metoclopramide Orally Disintegrating Tabs Pharmacokinetics
See Literature
Metoclopramide Orally Disintegrating Tabs Interactions
Interactions
Hypertensive crisis with MAOIs. Additive sedation with alcohol, other CNS depressants. Antagonized by anticholinergics and narcotics. Monitor insulin use; may diminish gastric and accelerate intestinal absorption of drugs or food.
Metoclopramide Orally Disintegrating Tabs Adverse Reactions
Adverse Reactions
Headache, nausea, vomiting, fatigue, somnolence, dizziness, extrapyramidal effects, parkinsonism, tardive dyskinesia, neuroleptic malignant syndrome, hypertension.
Metoclopramide Orally Disintegrating Tabs Clinical Trials
See Literature
Metoclopramide Orally Disintegrating Tabs Note
Notes
Formerly known under the brand name Metozolv ODT.
Metoclopramide Orally Disintegrating Tabs Patient Counseling
See Literature
Images
